Institutional Ownership Eton Pharmaceuticals, Inc. (ETON)
This table provides information about the institutional ownership of Eton Pharmaceuticals, Inc. (ETON). We have compiled data on the 88 institutions that hold shares in the stock, with a total of 14 Million shares, which have been reported (via 13F filing form) to have a value of $274 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
May 15, 2025 Q1 2025 |
1,500
shares
|
$29,400
0.0% of portfolio
|
Q1 2025
New holding
|
|
Truvestments Capital LLC
Sarasota, FL |
May 14, 2025 Q1 2025 |
1,183
shares
|
$23,186
0.0% of portfolio
|
Q3 2024
New holding
|
|
Wells Fargo & Company
San Francisco, CA |
May 13, 2025 Q1 2025 |
750
shares
|
$14,700
0.0% of portfolio
|
Q1 2025
Reduced 25.0%
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
May 08, 2025 Q1 2025 |
686
shares
|
$13,445
0.0% of portfolio
|
Q1 2025
Reduced 50.72%
|
|
Group One Trading, L.P.
Chicago, IL |
May 14, 2025 Q1 2025 |
634
shares
|
$12,426
0.0% of portfolio
|
Q1 2025
New holding
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
May 01, 2025 Q1 2025 |
100
shares
|
$1,960
0.0% of portfolio
|
Q1 2025
Reduced 29.08%
|
|
Caitong International Asset Management Co., LTD
Hong Kong, K3 |
May 13, 2025 Q1 2025 |
77
shares
|
$1,509
0.0% of portfolio
|
Q1 2025
New holding
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
1
shares
|
$19
0.0% of portfolio
|
Q1 2025
Reduced 100.0%
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|